Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7535 |
Intermediate Similarity |
NPD1058 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD1313 |
Approved |
0.689 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6828 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.681 |
Remote Similarity |
NPD6074 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6767 |
Remote Similarity |
NPD8836 |
Approved |
0.6748 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.6686 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6648 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD1215 |
Discontinued |
0.6645 |
Remote Similarity |
NPD4240 |
Approved |
0.6628 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.6622 |
Remote Similarity |
NPD248 |
Discontinued |
0.6607 |
Remote Similarity |
NPD2333 |
Discontinued |
0.6575 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6571 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6559 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6536 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6536 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.6522 |
Remote Similarity |
NPD6816 |
Phase 3 |
0.6457 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.6452 |
Remote Similarity |
NPD3695 |
Approved |
0.6452 |
Remote Similarity |
NPD3696 |
Approved |
0.645 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.6442 |
Remote Similarity |
NPD2524 |
Discontinued |
0.6409 |
Remote Similarity |
NPD3431 |
Approved |
0.6409 |
Remote Similarity |
NPD3430 |
Approved |
0.6404 |
Remote Similarity |
NPD2793 |
Discontinued |
0.6404 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6398 |
Remote Similarity |
NPD4568 |
Phase 2 |
0.6395 |
Remote Similarity |
NPD5324 |
Clinical (unspecified phase) |
0.6392 |
Remote Similarity |
NPD171 |
Discontinued |
0.6391 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.6379 |
Remote Similarity |
NPD3041 |
Approved |
0.6379 |
Remote Similarity |
NPD7111 |
Discontinued |
0.6364 |
Remote Similarity |
NPD6129 |
Phase 2 |
0.6364 |
Remote Similarity |
NPD1637 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.6364 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.6353 |
Remote Similarity |
NPD6794 |
Approved |
0.6343 |
Remote Similarity |
NPD5730 |
Phase 2 |
0.6343 |
Remote Similarity |
NPD40 |
Phase 2 |
0.6321 |
Remote Similarity |
NPD4352 |
Phase 1 |
0.6319 |
Remote Similarity |
NPD2839 |
Phase 2 |
0.6319 |
Remote Similarity |
NPD7722 |
Suspended |
0.6313 |
Remote Similarity |
NPD4902 |
Discontinued |
0.6307 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.6294 |
Remote Similarity |
NPD8121 |
Phase 3 |
0.6294 |
Remote Similarity |
NPD8120 |
Approved |
0.6292 |
Remote Similarity |
NPD5463 |
Clinical (unspecified phase) |
0.628 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6278 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.627 |
Remote Similarity |
NPD5462 |
Discontinued |
0.6265 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6265 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6264 |
Remote Similarity |
NPD3799 |
Suspended |
0.6264 |
Remote Similarity |
NPD7006 |
Approved |
0.6264 |
Remote Similarity |
NPD6761 |
Discontinued |
0.6263 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6263 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6263 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.6259 |
Remote Similarity |
NPD306 |
Approved |
0.6257 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD3409 |
Phase 1 |
0.625 |
Remote Similarity |
NPD8833 |
Approved |
0.625 |
Remote Similarity |
NPD1892 |
Phase 2 |
0.625 |
Remote Similarity |
NPD1893 |
Phase 2 |
0.625 |
Remote Similarity |
NPD8831 |
Approved |
0.6242 |
Remote Similarity |
NPD193 |
Suspended |
0.6242 |
Remote Similarity |
NPD1257 |
Approved |
0.623 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.623 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.623 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.623 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.623 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.6229 |
Remote Similarity |
NPD5843 |
Discontinued |
0.6229 |
Remote Similarity |
NPD2406 |
Clinical (unspecified phase) |
0.6226 |
Remote Similarity |
NPD174 |
Discontinued |
0.6222 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.6222 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.6222 |
Remote Similarity |
NPD5642 |
Approved |
0.6222 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.6222 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.6216 |
Remote Similarity |
NPD3362 |
Clinical (unspecified phase) |
0.6209 |
Remote Similarity |
NPD2818 |
Discontinued |
0.6199 |
Remote Similarity |
NPD509 |
Phase 3 |
0.6198 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6198 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6196 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.619 |
Remote Similarity |
NPD5300 |
Clinical (unspecified phase) |
0.6188 |
Remote Similarity |
NPD6418 |
Phase 1 |
0.6173 |
Remote Similarity |
NPD4183 |
Phase 3 |
0.6173 |
Remote Similarity |
NPD4182 |
Phase 3 |
0.6171 |
Remote Similarity |
NPD7297 |
Phase 2 |
0.6168 |
Remote Similarity |
NPD5969 |
Clinical (unspecified phase) |
0.6164 |
Remote Similarity |
NPD185 |
Approved |
0.6158 |
Remote Similarity |
NPD2364 |
Suspended |
0.615 |
Remote Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.615 |
Remote Similarity |
NPD6469 |
Phase 3 |
0.6149 |
Remote Similarity |
NPD6828 |
Phase 2 |
0.6149 |
Remote Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.6145 |
Remote Similarity |
NPD3612 |
Phase 2 |
0.6141 |
Remote Similarity |
NPD6577 |
Clinical (unspecified phase) |
0.6141 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.6138 |
Remote Similarity |
NPD4142 |
Discontinued |
0.6135 |
Remote Similarity |
NPD1690 |
Clinical (unspecified phase) |
0.6134 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.6133 |
Remote Similarity |
NPD2963 |
Phase 1 |
0.6129 |
Remote Similarity |
NPD4763 |
Clinical (unspecified phase) |
0.6126 |
Remote Similarity |
NPD5012 |
Phase 2 |
0.6124 |
Remote Similarity |
NPD1873 |
Clinical (unspecified phase) |
0.6124 |
Remote Similarity |
NPD4716 |
Approved |
0.6118 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6118 |
Remote Similarity |
NPD1288 |
Clinical (unspecified phase) |
0.6114 |
Remote Similarity |
NPD6521 |
Phase 3 |
0.6114 |
Remote Similarity |
NPD6520 |
Phase 3 |
0.6114 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.6108 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.6105 |
Remote Similarity |
NPD7988 |
Suspended |
0.6105 |
Remote Similarity |
NPD3889 |
Approved |
0.6102 |
Remote Similarity |
NPD2731 |
Phase 2 |
0.6102 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.6096 |
Remote Similarity |
NPD2880 |
Discontinued |
0.6089 |
Remote Similarity |
NPD1674 |
Clinical (unspecified phase) |
0.6089 |
Remote Similarity |
NPD5806 |
Clinical (unspecified phase) |
0.6089 |
Remote Similarity |
NPD1675 |
Phase 1 |
0.6089 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.6087 |
Remote Similarity |
NPD249 |
Approved |
0.6087 |
Remote Similarity |
NPD166 |
Approved |
0.6087 |
Remote Similarity |
NPD250 |
Approved |
0.6084 |
Remote Similarity |
NPD1027 |
Approved |
0.6084 |
Remote Similarity |
NPD1030 |
Approved |
0.6084 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.6082 |
Remote Similarity |
NPD3860 |
Discontinued |
0.6071 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6071 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6071 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.6069 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.6067 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6067 |
Remote Similarity |
NPD3432 |
Approved |
0.6066 |
Remote Similarity |
NPD7504 |
Discontinued |
0.6062 |
Remote Similarity |
NPD7445 |
Phase 1 |
0.6058 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.6056 |
Remote Similarity |
NPD4441 |
Phase 2 |
0.6053 |
Remote Similarity |
NPD6151 |
Phase 2 |
0.6053 |
Remote Similarity |
NPD4318 |
Clinical (unspecified phase) |
0.6048 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.6044 |
Remote Similarity |
NPD5757 |
Discontinued |
0.6037 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.6036 |
Remote Similarity |
NPD2150 |
Discontinued |
0.6034 |
Remote Similarity |
NPD702 |
Clinical (unspecified phase) |
0.6033 |
Remote Similarity |
NPD5145 |
Clinical (unspecified phase) |
0.6026 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.6025 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.6021 |
Remote Similarity |
NPD2807 |
Discontinued |
0.602 |
Remote Similarity |
NPD4863 |
Approved |
0.6012 |
Remote Similarity |
NPD186 |
Discovery |
0.6012 |
Remote Similarity |
NPD195 |
Approved |
0.6011 |
Remote Similarity |
NPD4155 |
Approved |
0.6011 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.601 |
Remote Similarity |
NPD6271 |
Approved |
0.601 |
Remote Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6 |
Remote Similarity |
NPD1895 |
Discontinued |
0.6 |
Remote Similarity |
NPD757 |
Phase 3 |
0.6 |
Remote Similarity |
NPD1658 |
Discontinued |
0.6 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.6 |
Remote Similarity |
NPD1869 |
Phase 2 |
0.599 |
Remote Similarity |
NPD4854 |
Phase 3 |
0.5989 |
Remote Similarity |
NPD2868 |
Clinical (unspecified phase) |
0.5989 |
Remote Similarity |
NPD5666 |
Phase 2 |
0.5988 |
Remote Similarity |
NPD2149 |
Clinical (unspecified phase) |
0.598 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.5979 |
Remote Similarity |
NPD5885 |
Approved |
0.5978 |
Remote Similarity |
NPD2729 |
Approved |
0.5978 |
Remote Similarity |
NPD2730 |
Approved |
0.5978 |
Remote Similarity |
NPD2728 |
Approved |
0.5977 |
Remote Similarity |
NPD3361 |
Phase 1 |
0.5976 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.5962 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.5959 |
Remote Similarity |
NPD4446 |
Approved |
0.5956 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5955 |
Remote Similarity |
NPD5943 |
Clinical (unspecified phase) |
0.595 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.5949 |
Remote Similarity |
NPD2443 |
Approved |
0.5949 |
Remote Similarity |
NPD2442 |
Approved |
0.5948
|
Remote Similarity |
NPD1354 |
Approved |